AJP - Endo AJP: Heart and Circulatory Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Endocrinol Metab (January 2, 2008). doi:10.1152/ajpendo.00560.2007
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
294/3/E568    most recent
00560.2007v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Erdmann, J.
Right arrow Articles by Schusdziarra, V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Erdmann, J.
Right arrow Articles by Schusdziarra, V.
Submitted on August 29, 2007
Accepted on December 30, 2007

Development of hyperinsulinemia and insulin resistance during the early stage of weight gain

Johannes Erdmann1*, Bianca Kallabis1, Ulrich Oppel2, Oleg Sypchenko2, Stefan Wagenpfeil3, and Volker Schusdziarra4

1 Else-Kroner-Fresenius Center of Nutritional Medicine, Technical University of Munich, Munich, Germany
2 Department of Mathematics, Ludwig Maximilians University of Munich, Munich, Germany
3 Department of Medical Statistics and Epidemiology, Technical University of Munich, Munich, Germany
4 Technical University of Munich, Department of Internal Medicine II, Germany; Else-Kroner-Fresenius Center of Nutritional Medicine, Germany

* To whom correspondence should be addressed. E-mail: johannes.erdmann{at}lrz.tum.de.

Objective: Obesity is associated with insulin resistance and hyperinsulinemia which is considered to be a core component in the pathophysiology of obesity related co-morbidities. As yet it is unknown if insulin resistance and hyperinsulinemia already develop during weight gain within the normal range. Methods: In 10 healthy male subjects the effect of intentional weight gain by 2 BMI-points was examined on insulin. C-peptide and glucose levels following a meal, 75g glucose and a two-step hyperglycemic clamp increasing plasma glucose by 1.38 and 2.75mmol/l, respectively. Results: Baseline insulin, C-peptide and glucose concentrations were significantly higher after weight gain from BMI 21.8kg/m2 to 23.8kg/m2 within 4.5 months. Calculations of insulin-secretion and clearance indicate that reduced insulin clearance contributes more to post weight gain basal hyperinsulinemia than insulin secretion. Following oral or i.v.-stimulation insulin concentrations were significantly higher post weight gain during all three test conditions while C-peptide and glucose levels did not differ. Calculations of insulin secretion and clearance demonstrated that higher stimulated insulin concentrations are entirely due to clearance but not secretion. Despite significantly higher insulin levels the rate of i.v.-glucose required to maintain the defined elevation of glucose levels was either identical (1.38mmol/l) or even significantly lower (2.75mmol/l) following weight gain. Conclusion: The present study demonstrates for the first time that insulin resistance develops already during weight gain within the normal range of body weight. The associated basal and stimulated hyperinsulinemia is the result of differentiated changes of insulin secretion and clearance, respectively.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 2008 by the American Physiological Society.